1、Designation:D4774111Standard Specification forUser Applied Drug Labels in Anesthesiology1This standard is issued under the fixed designation D4774;the number immediately following the designation indicates the year oforiginal adoption or,in the case of revision,the year of last revision.A number in
2、parentheses indicates the year of last reapproval.Asuperscript epsilon()indicates an editorial change since the last revision or reapproval.1NOTEFigures 1-6 were corrected editorially in April 2012.1.Scope1.1 This specification covers the size,color,pattern,andtype used on labels applied to unlabele
3、d syringes filled by theusers or their agents to identify the drug content.This speci-fication is not intended to cover labels applied by the drugmanufacturer.1.2 The values stated in SI units are to be regarded as therecommended values.The use of inch-pound system values,not being exact equivalents
4、,may result in nonconformancewith the standard.1.3 This standard does not purport to address all of thesafety concerns,if any,associated with its use.It is theresponsibility of the user of this standard to establish appro-priate safety and health practices and determine the applica-bility of regulat
5、ory limitations prior to use.2.Referenced Documents2.1 ASTM Standards:2D996 Terminology of Packaging and Distribution Environ-ments2.2 Other Standard:Pantone Matching System33.Terminology3.1 DefinitionsGeneral definitions for packaging and dis-tribution environments are found in Terminology D996.4.S
6、ize and Background Color Requirements4.1 Label SizeThe labels shall have a nominal length of 25to 35 mm and a width of 10 to 13 mm.4.2 Label Background ColorThe colors and patterns givenin Fig.1 shall be used to distinguish these groups of drugs.Thebackground color shall not interfere with the abili
7、ty of the userto write information on the label.4.2.1 AntagonistsTo denote an antagonist,1-mm widediagonal stripes of the agonist color alternating with a 1-mmwide white stripe shall be used.The stripes shall run from thelower left to the upper right at an angle of approximately 45to the long axis o
8、f the label.The name of an antagonist drugshall appear in the center of the label and the striping shall beomitted behind and below the name(see Fig.2).1This specification is under the jurisdiction of ASTM Committee D10 onPackaging and is the direct responsibility of Subcommittee D10.32 on Consumer,
9、Pharmaceutical,Medical,and Child Resistant Packaging.Current edition approved April 1,2011.Published May 2011.Originallyapproved in 1988.Last previous edition approved in 2006 as D4774 06.DOI:10.1520/D4774-11E01.2For referenced ASTM standards,visit the ASTM website,www.astm.org,orcontact ASTM Custom
10、er Service at serviceastm.org.For Annual Book of ASTMStandards volume information,refer to the standards Document Summary page onthe ASTM website.3Available from Pantone,Inc.,509 Commerce Boulevard,Carlstadt,NJ070723098.Copyright ASTM International,100 Barr Harbor Drive,PO Box C700,West Conshohocken
11、,PA 19428-2959.United States1 5.Significance and Use5.1 The objective of this specification is to facilitate iden-tification of drugs in syringes filled by the user.The use ofcolors is intended only as an aid in identification of drug groupsand does not absolve the user from the duty to read the lab
12、el tocorrectly identify the drug prior to use.FIG.1 Standard Background Colors for User Applied Syringe Drug LabelsFIG.2 Label for an Antagonist DrugD4774 1112 5.2 The user may alternatively use black and white labelsrather than these colored labels.6.Type and Color Requirements6.1 The type should b
13、e as large as possible(minimum10-point)using bold type.Upper and lower case letters arepreferred for better legibility.All printing shall be in black boldwith the exception of“SUCCINYLCHOLINE,“EPINEPH-RINE and Beta Blockers“ESMOLOL”,METOPROLOL”,“LABATOLOL”which shall be printed against the backgroun
14、dcolor as bold reverse plate letters within a black bar(copper barfor Beta Blockers)running from edge to edge on the upper halfof the label,the rest of which shall display the coloredbackground(see Fig.3).6.1.1 The established(generic)name of the drug shall beused.The use of the proprietary(trade)na
15、me of the drug isoptional.The initial syllable,or initial two syllables,of thedrug name may be emphasized by being printed in a bold uppercase type a minimum of 2 points larger than the remainder ofthe drug name,which is typed in lower case(see Fig.4).6.1.2 Except for antagonists,the name of the dru
16、g andconcentration(for example,“mg/mL,”“meq/mL,”or“mcg/mL”;see Fig.3 and Fig.5)should be printed on the upper halfof the label to leave space below for entry of the date,time,andinitials of user).6.1.3 For induction agents and local anesthetics the concen-tration of the solution(as“%or“mg/mL)and the date ofpreparation should appear on the label,as shown in Fig.6.6.1.4 For antagonists the name of the drug should be printedalong the center line of the label to permit a sufficient width ofdiagonal
